Vitality Watch

Dossier pubmed preclinical 06-oct-2026
Animal model, organoid, or cell-culture result — not yet human

PI3K is the dominant signalling pathway recruited by IRS proteins to mediate their effects on metabolism and growth.

Key claim: In mice, PI3K recruitment by IRS1 or IRS2 is the primary mediator of their effects on growth and metabolism, whereas GRB2 recruitment is dispensable for these phenotypes.

Abstract

OBJECTIVES: Insulin and Igf1 have pleiotropic effects on development, growth and metabolism. The activated insulin and IGF1 receptors engage insulin receptor substrate (IRS) proteins, intracellular adaptor molecules that recruit multiple downstream signalling pathways, including PI3K and GRB2-RAS-MAPK. Global deletion of IRS1 or IRS2 in mice results in divergent effects on growth, metabolism, and ageing. However, the precise signalling pathways recruited by IRS1 or IRS2 to mediate their physiological effects in vivo have not been defined. METHODS: We generated knock-in mice in which either IRS1 or IRS2 was mutated to prevent downstream recruitment of PI3K or GRB2 and undertook phenotypic analysis of these animals. RESULTS: Knock-in mice unable to recruit PI3K to IRS1 (Irs1) or to IRS2 (Irs2) had limited or no compensation in IRS2 and IRS1 signalling respectively. Irs1mice were growth restricted, with reduced adiposity and insulin resistance, but did not develop diabetes due to compensatory increase in β-cell mass. Irs2mice were obese and insulin resistant and developed diabetes due to β-cell failure. In contrast knock-in mice unable to recruit GRB2 to IRS1 (Irs1) or to IRS2 (Irs2) displayed normal growth and metabolism. CONCLUSIONS: PI3K recruitment by either IRS1 or IRS2 is the primary signalling mediator of the effects of these adaptor molecules on growth and metabolism in mice, and suggest that the other signalling pathways recruited by IRS1 and IRS2, including GRB2, have minimal or redundant roles.

Why this matters

The IRS1/IRS2 adaptors sit at the junction where insulin and IGF-1 signals bifurcate into PI3K–AKT–mTOR (growth, metabolism) and GRB2–Ras–MAPK (proliferation) arms, and most pharmacology aimed at longevity hits the PI3K/mTOR arm. Clean mouse genetics showing that growth and metabolic phenotypes depend on PI3K recruitment, with GRB2 recruitment dispensable, narrows the causal pathway from GH/IGF-1 tone to the mTOR hallmark and lowers the plausibility of GRB2-arm contributions to IIS-related aging phenotypes in mammals.

Source

Link

Briefing card

PI3K is the dominant signalling pathway recruited by IRS proteins to mediate their effects on metabolism and growth.
Stage: preclinical · pubmed · 06-oct-2026

If you follow rapamycin, acarbose, or GH/IGF-1-lowering strategies, this reinforces that the PI3K–AKT–mTOR branch (not the MAPK branch) is the arm those interventions act through downstream of insulin/IGF-1.

In mice, PI3K recruitment by IRS1 or IRS2 is the primary mediator of their effects on growth and metabolism, whereas GRB2 recruitment is dispensable for these phenotypes.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.molmet.2026.102450

build build 880 · 2bcef25 · 2026-11-18